ClearBridge Value Fund Class A
LGVAX
NASDAQ
| Weiss Ratings | LGVAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Fair | |||
| Reward Grade | C | |||
| Risk Index | Good | |||
| Risk Grade | B | |||
| Company Info | LGVAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Provider | Franklin Templeton Investments | |||
| Manager/Tenure (Years) | Sam Peters (14), Jean Yu (12), Reed Cassady, CFA (1) | |||
| Website | http://www.franklintempleton.com | |||
| Fund Information | LGVAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Fund Name | ClearBridge Value Fund Class A | |||
| Category | Large Value | |||
| Sub-Category | US Equity Large Cap Value | |||
| Prospectus Objective | Growth | |||
| Inception Date | Feb 02, 2009 | |||
| Open/Closed To New Investors | Open | |||
| Minimum Initial Investment | 1,000.00 | |||
| Minimum Subsequent Investment | 50.00 | |||
| Front End Fee | 0.06 | |||
| Back End Fee | -- | |||
| Dividends and Shares | LGVAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Yield | 0.77% | |||
| Dividend | LGVAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Yield (Forward) | 2.14% | |||
| Asset Allocation | LGVAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash | 2.15% | |||
| Stock | 97.85% | |||
| U.S. Stock | 85.35% | |||
| Non-U.S. Stock | 12.50% | |||
| Bond | 0.00% | |||
| U.S. Bond | 0.00% | |||
| Non-U.S. Bond | 0.00% | |||
| Preferred | 0.00% | |||
| Convertible | 0.00% | |||
| Other Net | 0.00% | |||
| Price History | LGVAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -0.19% | |||
| 30-Day Total Return | 3.03% | |||
| 60-Day Total Return | 4.39% | |||
| 90-Day Total Return | 12.89% | |||
| Year to Date Total Return | 3.31% | |||
| 1-Year Total Return | 8.07% | |||
| 2-Year Total Return | 24.91% | |||
| 3-Year Total Return | 51.39% | |||
| 5-Year Total Return | 115.49% | |||
| Price | LGVAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Closing Price | -- | |||
| 1-Month Low Price | -- | |||
| 1-Month High Price | -- | |||
| 52-Week Low Price | -- | |||
| 52-Week Low Price (Date) | -- | |||
| 52-Week High Price | -- | |||
| 52-Week High Price (Date) | -- | |||
| NAV | LGVAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Nav | $97.53 | |||
| 1-Month Low NAV | $95.03 | |||
| 1-Month High NAV | $98.42 | |||
| 52-Week Low NAV | $82.19 | |||
| 52-Week Low NAV (Date) | Apr 08, 2025 | |||
| 52-Week High NAV | $112.03 | |||
| 52-Week High Price (Date) | Nov 29, 2024 | |||
| Beta / Standard Deviation | LGVAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 1.02 | |||
| Standard Deviation | 16.92 | |||
| Balance Sheet | LGVAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Total Assets | 3.85B | |||
| Operating Ratios | LGVAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Expense Ratio | 1.01% | |||
| Turnover Ratio | 54.00% | |||
| Performance | LGVAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Last Bull Market Total Return | 16.90% | |||
| Last Bear Market Total Return | -15.00% | |||